Journal of Applied Biotechnology Reports (JABR) is a quarterly, international, peer-reviewed, and open-access journal dedicated to the various disciplines of Applied Biotechnology. The journal publishes original/research articles, review articles, mini-reviews, short communication, letters to the editors, commentaries, and editorials.

Journal of Applied Biotechnology Reports (JABR) is the new presentation and publication resource for biotechnology researchers. The journal publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. It provides a medium for the rapid publication of full-length articles, short communications, and technical reports on novel and innovative aspects of biotechnology. The Journal of Applied Biotechnology Reports also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author's CV to the editorial office. The journal will have 4 issues per year that are published concurrently in English and all officially accepted manuscripts will be immediately published online. The journal also encourages the submission of useful reports of negative results.

Submitted manuscripts should present new results of original research or describe new theoretical or methodological approaches in biotechnology. Original experimental papers of pressing nature requiring rapid publication no longer than five typewritten pages, including figures, tables, and references, are published in the Short Communications section. The Journal will accept papers in all of the biotechnology areas especially DNA/Protein Engineering, all of Cell Analysis fields (Genomics, Proteomics, Metabolomics, Systems biology etc.), Bioinformatics (Docking and Modeling), Imaging, Analytical Biotechnology (Sensors/Detectors for Analytes/Macromolecules), Plant/Agricultural, Food, Microbial or Environmental Biotechnology, Health and Therapeutical Biotechnology (Including Antisense/siRNAs and PNAs, Enzymes, Peptides ...), Regenerative Medicine (Stem cells, Tissue engineering, and Biomaterials), Translational Immunology (Antibody engineering, Xenotransplantation, T-cell therapies), Medical Biotechnology, Biosafety or Biosecurity.

Starting with April 2021, JABR will receive 5,000,000 Rials as an article processing charge for accepted original, Review, and short communication articles. Also, the article processing charge for authors in other countries from the beginning of 2022 is $ 300. Please note that these fees apply only to accepted articles.

Frequency: 4 Issues Per Year